I-Furosemide CAS 54-31-9 Assay ≥99.0% I-Diuretic API Factory High Quality
I-Furosemide kanye Nezixhumanisi Ezihlobene:
I-Furosemide CAS 54-31-9
2,4-Dichloro-5-Sulfamoylbenzoic Acid CAS 2736-23-4
I-2,4-Dichlorobenzoic Acid CAS 50-84-0
| Igama Lekhemikhali | I-Furosemide |
| Omqondofana | 5-(Aminosulfonyl) -4-chloro-2-[(2-furanylmethyl)amino]benzoic Acid;I-4-Chloro-N-furfuryl-5-sulfamoylanthranilic Acid |
| Inombolo ye-CAS | 54-31-9 |
| Inombolo yeCAT | I-RF-API102 |
| Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
| I-Molecular Formula | I-C12H11ClN2O5S |
| Isisindo samangqamuzana | 330.74 |
| Ukuncibilika | I-Soluble ku-acetone, i-DMF, i-Methanol;Ayincibiliki Emanzini |
| Ibhrendi | I-Ruifu Chemical |
| Into | Imininingwane |
| Ukubukeka | I-Crystalline Powder Emhlophe noma Engamhlophe;Ayinaphunga, Icishe Ayinambitheki |
| I-Furosemid | ≥99.0% |
| I-Melting Point | 206.0~210.0℃ |
| I-Absorption Coefficient | 565~595 |
| I-Chloride | ≤0.014% |
| I-sulfate | ≤0.04% |
| Ukulahlekelwa Ekumisweni | ≤0.50% |
| Izinsalela ekushiseni | ≤0.10% |
| Izinsimbi Ezisindayo | ≤20ppm |
| I-Arsenic | ≤2ppm |
| Izinga Lokuhlola | I-Enterprise Standard |
| Ukusetshenziswa | Pharmaceutical Intermediates |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.
I-Frusemide iyi-loop diuretics esetshenziswa kakhulu ekwelapheni ukwehluleka kwenhliziyo okuminyanisa kanye ne-edema.I-Frusemide, ethengiswa ngaphansi kwegama lomkhiqizo i-Lasix phakathi kokunye, umuthi osetshenziselwa ukwelapha ukugcwala koketshezi ngenxa yokwehluleka kwenhliziyo, izibazi zesibindi, noma isifo sezinso.Ingase futhi isetshenziselwe ekwelapheni high blood pressure.Furosemid isetshenziswa ngokuyinhloko ekwelapheni hypertension kanye edema.Kuyi-ejenti yomugqa wokuqala kubantu abaningi abane-edema ebangelwa ukwehluleka kwenhliziyo okuminyanisa.Ibuye isetshenziselwe i-hepaticcirrhosis, ukukhubazeka kwezinso, i-nephrotic syndrome, ekwelapheni okuhambisanayo kwe-cerebral noma i-pulmonary edema lapho kudingeka khona i-rapidiuresis (umjovo we-IV), nasekulawuleni i-hypercalcemia enzima ngokuhambisana nokubuyisela amanzi okwanele.
